Bicycle Therapeutics PLC (BCYC)
21.38
-0.80
(-3.63%)
USD |
NASDAQ |
May 17, 16:00
21.38
0.00 (0.00%)
Pre-Market: 20:00
Bicycle Therapeutics 1 Year Total Returns (Daily): -11.48% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | -11.48% |
| May 16, 2024 | -7.20% |
| May 15, 2024 | -6.33% |
| May 14, 2024 | -9.56% |
| May 13, 2024 | -6.58% |
| May 10, 2024 | -2.05% |
| May 09, 2024 | 5.41% |
| May 08, 2024 | 9.35% |
| May 07, 2024 | 6.16% |
| May 06, 2024 | 7.18% |
| May 03, 2024 | 12.60% |
| May 02, 2024 | 20.50% |
| May 01, 2024 | 17.08% |
| April 30, 2024 | 18.67% |
| April 29, 2024 | 18.47% |
| April 26, 2024 | 13.71% |
| April 25, 2024 | 12.88% |
| April 24, 2024 | 12.28% |
| April 23, 2024 | 13.40% |
| April 22, 2024 | 12.85% |
| April 19, 2024 | 19.70% |
| April 18, 2024 | 25.20% |
| April 17, 2024 | 7.49% |
| April 16, 2024 | 15.73% |
| April 15, 2024 | 15.15% |
| Date | Value |
|---|---|
| April 12, 2024 | 11.28% |
| April 11, 2024 | 4.99% |
| April 10, 2024 | 8.39% |
| April 09, 2024 | 3.83% |
| April 08, 2024 | 3.33% |
| April 05, 2024 | 7.07% |
| April 04, 2024 | 7.51% |
| April 03, 2024 | 8.11% |
| April 02, 2024 | 11.57% |
| April 01, 2024 | 14.01% |
| March 28, 2024 | 11.16% |
| March 27, 2024 | 21.72% |
| March 26, 2024 | 19.37% |
| March 25, 2024 | 23.75% |
| March 22, 2024 | 23.02% |
| March 21, 2024 | 22.92% |
| March 20, 2024 | 20.23% |
| March 19, 2024 | 13.03% |
| March 18, 2024 | 11.05% |
| March 15, 2024 | 10.56% |
| March 14, 2024 | 5.91% |
| March 13, 2024 | 20.63% |
| March 12, 2024 | 25.07% |
| March 11, 2024 | 18.23% |
| March 08, 2024 | 20.14% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-63.30%
Minimum
Oct 14 2022
239.1%
Maximum
Dec 31 2021
40.45%
Average
33.89%
Median
Jul 05 2023
1 Year Total Returns (Daily) Benchmarks
| Biodexa Pharmaceuticals Plc | -93.53% |
| NuCana PLC | -81.20% |
| TC BioPharm (Holdings) PLC | -93.27% |
| Adaptimmune Therapeutics PLC | -17.16% |
| Verona Pharma PLC | -33.09% |